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SUMMARY – The aim of this study was to compare and evaluate clinical results before and after 
vertebroplasty in the treatment of myeloma-induced vertebral fractures. Success of the surgery was 
defined by increased or reduced pain intensity before and after the treatment, as assessed using the 
visual analog scale (VAS). The study was designed as a retrospective-prospective study. The study in-
cluded 26 patients, 14 women and 12 men. Data on patients treated for myeloma-induced vertebral 
fractures were collected at the Department of Orthopedics, Osijek University Hospital Centre. The 
following data were analyzed: gender, duration of illness, intensity of pain before and after treatment 
(using VAS), radiological changes before and after treatment, grade of vertebral fracture, and extracor-
poreal cement leakage from the vertebral body to the surrounding tissue during the procedure. Differ-
ence in pain intensity before and after the surgery was statistically significant. All patients complained 
of pain before the surgery (pain intensity median 8), whereas after the surgery, pain intensity decreased 
in all patients (pain intensity median 2). In conclusion, improvement in clinical results of the treat-
ment of myeloma-induced vertebral fractures with vertebroplasty proved to be significant.
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Introduction
Vertebroplasty as a minimally invasive surgical pro-
cedure for treatment of vertebral body compression frac-
tures due to osteoporosis, secondary tumors and multiple 
myeloma contributes to significant pain reduction and 
improved quality of life1. Most patients with myeloma 
have both diffuse and localized involvement of bone tis-
sue in myeloma cells. In addition, the cytokine-mediated 
imbalance of the osteoclastic (bone resorption) and os-
teoblastic (reconstruction) function leads to systemic 
osteoporosis and spontaneous fractures2,3.
Although vertebroplasty has been widely used 
since 1984, there are no major studies related to the 
effect of this surgical method with regard to plasmacy-
toma, which is not the case when it comes to osteopo-
rotic fractures.
The aim of this prospective-retrospective study was 
to examine the success of vertebroplasty as a surgical 
method in the treatment of pathologic fractures of the 
vertebrae, by comparing the patient clinical picture be-
fore and after surgical procedure. Success was defined by 
reduction in pain intensity measured before and after the 
procedure using the visual analog scale (VAS).
Patients and Methods
For the purpose of the research, we collected his-
tory data on patients with plasmacytoma treated with 
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vertebroplasty at the Department of Orthopedics, 
Osijek University Hospital Centre in the last ten years. 
Based on the medical documentation available, the 
following general data were analyzed: gender, duration 
of the illness, level of pain before and after the surgery 
(VAS), radiological changes in the operated segment 
before and after the procedure, especially the grade of 
fracture, and existence of extracorporeal leakage of ce-
ment during the procedure. VAS is the most common-
ly used scale for measuring pain intensity. Patients 
filled out a questionnaire immediately before the pro-
cedure and three weeks after it. Vertebral body angle of 
inclination was measured before and after the proce-
dure by latero-lateral radiograph (Fig. 1).
All patients underwent vertebroplasty. The patient 
was placed in a prone position (significant kyphosis 
correction was achieved and the height of the col-
lapsed vertebral body was increased by up to 10%). The 
fractured vertebra was located with an image intensi-
fier and the operative field was prepared and covered. 
If the procedure was performed under local anesthesia, 
skin and subcutaneous tissue to the periosteum were 
anesthetized with 2% lidocaine. If the patient could 
not tolerate pain, the procedure was performed under 
general anesthesia. The 11-gauge bone biopsy needle 
was placed in the anterior third of the vertebral body. 
The procedure could be unipedicular or bipedicular. 
When the needle position was satisfactory, a separate 
thin needle for vertebral body biopsy, included in the 
vertebroplasty kit, was placed in the vertebral body 
through the previously inserted needle. The material 
obtained was sent for histopathologic analysis (Fig. 2).
After that, bone cement of appropriate viscosity 
was applied to the vertebral body. It was very impor-
Fig. 1. Wedge angle before (A) and after (B) vertebroplasty.
Fig. 2. Bone biopsy.
Fig. 3. Postoperative x-ray.
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tant to control the procedure with an image intensifier 
to avoid leakage of the cement and various resulting 
complications. The cement was applied until its posi-
tion in the last quarter of the vertebral body was satis-
factory, or until the occurrence of epidural, intravenous 
or intradiscal cement extravasation (Fig. 3).
With 15% of vertebral body filled with cement (ap-
proximately 3.5 mL), satisfactory strength of the bro-
ken vertebral body was achieved. In all the procedures 
analyzed, high-viscosity cement was used (Confidence, 
De Puy, Raynham, Massachusetts, USA). The patient 
remained on bed rest for at least one hour, and was 
discharged 24 hours after the procedure4. Three weeks 
after the procedure, during the first follow-up exami-
nation scheduled to obtain histopathologic findings, 
the patients filled out the questionnaire again.
Statistical analysis
Categorical data were represented by absolute fre-
quencies. Gender-based differences in fracture classifi-
cation were tested using Fisher exact test. Numerical 
data were described by median and limits of interquar-
tile range. Normal distribution of numerical variables 
was tested by Shapiro-Wilk test. Differences in VAS 
assessed pain intensity before and after the surgery 
were tested by Wilcoxon test5. All p values were two-
sided. The level of significance was set at Alpha=0.05. 
For statistical analysis, the MedCalc Statistical, soft-
ware version 14.12.0 (MedCalc Software BV, Ostend, 
Belgium; 2014) statistical program was used.
Results
The research was conducted on 26 patients having 
undergone vertebroplasty procedure for pathologic 
vertebral body fracture due to the primary disease, 
plasmacytoma; there were 12 male and 14 female pa-
tients. Most of the patients, six of them, sustained 
TH11, TH12 and L1 fractures; two patients sustained 
TH6 and TH10 fractures; L2 and L3 were fractured 
in five patients; L3 was fractured in three patients, and 
only one patient had TH7 vertebral body fracture. Two 
fractured vertebrae were found in ten patients.
According to the Genant classification of vertebral 
fractures6, depending on whether the fracture was 
complete or not, the patients were divided into three 
fracture grades: nine patients had fractures where 25% 
of the vertebral body height was collapsed, thirteen pa-
tients had 26% to 40% of the height of the vertebral 
body collapsed, and four patients had more than 40% 
of the vertebral body height collapsed. There were no 
significant gender differences in fracture classification 
(Table 1).
Before and after the surgery, the patients evaluated 
pain intensity using the VAS. There was significant 
postoperative reduction (75%), median 2 (interquartile 
range 1.75-3), ranging from 1 to 4, compared to pre-
surgery period (Wilcoxon test, p<0.001) (Table 2).
During the procedure, cement leakage occurred in 
eight (30.7%) patients.
After vertebroplasty, we noticed minor correction 
of the angle of inclination of the fractured vertebral 
body (Fig. 4).
Discussion
This research has revealed that there are very few 
reports on the efficiency and safety of using vertebro-
Table 1. Fracture classification (Gęnant) by gender
Number of patients p*Men Women Total
Grade I  
(collapse up to 25% 




Grade II  
(collapse from 26% 
to 40% of vertebral 
body height)
5/12 8/14 13/26
Grade III  
(collapse more than 
40% of vertebral 
body height)
1/12 3/14 4/26
Total 12/12 14/14 26/26
*Fisher exact test
Table 2. Assessment of pain intensity before and  
after surgery using visual analog scale (VAS)
Median (interquartile range) p*Before surgery After surgery
VAS 8 (7-9) 2 (1.75-3) <0.001
*Wilcoxon test
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plasty in treating plasmacytoma-induced vertebral 
fractures. Furthermore, all such reports are limited by 
the number of patients and the results reported.
Our analysis demonstrated that vertebroplasty en-
abled direct reduction of pain intensity immediately 
and three weeks following the procedure. This pain re-
duction was not only clinically significant (i.e. change 
from score 8.0 to 2.0 on the VAS, which is equivalent 
to 75% reduction)7, but it also was very beneficial be-
cause most patients experienced intense pain that 
could not be relieved by analgesics or conventional 
medical therapy8. When analyzing the quality of life 
before and after vertebroplasty, Rapan et al.9 found 
that as many as 91.8% of patients were satisfied with 
their postoperative status, and that the same number 
of patients would be willing to repeat the procedure in 
the event of a repeated fracture.
The mechanism of pain reduction has so far been 
based on the assumption of stabilization of painful 
fragments and thermal effect occurring during polym-
erization of cement, which would essentially cauterize 
nerve endings10. Khan et al.11 found similarities in the 
success of treating vertebral fractures caused by osteo-
porosis and those caused by plasmacytoma.
Teng et al.12 proved that, following vertebroplasty, 
the angle of deformity improved significantly, both in 
the entire spinal column and in the vertebral wedge 
(7.4 degrees). In our research, we also found improve-
ment of the wedge angle (4.3 degrees), but not to the 
extent indicated by the authors mentioned above.
In terms of safety, it seems that vertebroplasty is a 
safe procedure. Although vertebroplasty was per-
formed under local anesthesia in our case, the patients 
tolerated it well and we had no serious complications 
such as pulmonary embolism or infection to report.
Cement leakage occurred in approximately 30.7% 
of all treated levels. Leakage was asymptomatic in all 
cases. Results indicated that about 10% of the patients 
would develop new changes in their spine within two 
years following the treatment. It seems that the devel-
opment of new spinal fractures is more frequent (oc-
curs almost twice as often) in patients with multiple 
myeloma than in metastases. This is no surprise con-
sidering the fact that there are several studies indicat-
ing that patients suffering from plasmacytoma are 
more sensitive to fractures13-16. Generally speaking, 
data indicate that the frequency of new fractures after 
vertebroplasty intervention is no greater than the 
spontaneous occurrence of new spinal fractures (19%-
24%) reported in patients who had not been previ-
ously treated17.
At present, there is an obvious lack of studies that 
would draw comparisons between kyphoplasty and 
other interventions, both invasive and noninvasive. 
Current results indicate that kyphoplasty and verte-
broplasty provide similar reduction of pain intensity, 
but that kyphoplasty is also linked to a lower rate of 
cement leakage, as evident in other studies10,16-18. Also, 
in cases where high-viscosity cement was used as op-
posed to low-viscosity cement in osteoporotic frac-
tures, there was a significantly lower rate of cement 
leakage19.
When compared to previous studies in our group 
and to other studies aimed at evaluating the efficiency 
of vertebroplasty in benign osteoporotic fractures, we 
found similar but yet not identical short-term and 
long-term outcomes. Specifically, our analysis at treat-
ment level was very similar to previous studies of be-
nign compressive fractures in terms of distribution5, 
suggesting that the prevalence/level of symptomatic 
compression fractures in patients with plasmacytoma 
is no different from that in osteoporotic patients with 
painful fractures. Certain limitations that apply to this 
study could be attributed to the nature of retrospective 
studies as such, small number of patients and short pe-
riod of observation.
Conclusion
Based on the research conducted and the results 
obtained, the following conclusions can be drawn:
Fig. 4. Wedge angle before and after vertebroplasty.
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•	 After vertebroplasty, pain in the area of fractured 
vertebrae was significantly reduced.
•	 In eight (30.7%) patients, cement leakage oc-
curred during surgery, which did not affect the 
success of the procedure.
•	 Vertebroplasty increases the height of the frac-
tured vertebra and reduces the wedge angles.
•	 Vertebroplasty (with high-viscosity cement) is 
an efficient and safe method of treatment of ver-
tebral body fractures caused by plasmacytoma.
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Sažetak
VERTEBROPLASTIKA U LIJEČENJU PLAZMACITOMA
V. Kolarević, I. Vidaković, M. Šutalo, V. Rapan, D. Rapan i S. Rapan
Cilj rada bio je ispitati uspješnost operacijske metode vertebroplastike u liječenju patološkog prijeloma trupa kralješka, i 
to usporedbom kliničke slike prije i nakon operacijskog zahvata. Uspješnost se definirala smanjenjem ili povećanjem inten-
ziteta boli pomoću ljestvice VAS prije i nakon operacijskog zahvata. Istraživanje je provedeno kao retrospektivno-prospek-
tivna studija, a obuhvatilo je 26 bolesnika, od toga 14 žena i 12 muškaraca. Iz medicinske dokumentacije Zavoda za ortope-
diju KBC-a Osijek prikupljeni su podatci o bolesnicima koji su liječeni vertebroplastikom zbog prijeloma kralješka uslijed 
plasmacitoma. Analizirani su sljedeći podatci: spol, dužina trajanja tegoba, razina bolova prije i poslije operacije (pomoću 
ljestvice VAS) te radiološke promjene na operiranom segmentu prije i poslije zahvata, naročito stupanj prijeloma te postoja-
nje ekstrakorporalnog istjecanja cementa tijekom zahvata. Zabilježene su statistički značajne razlike u bolovima prije i nakon 
obavljene vertebroplastike koje su govorile u prilog uspješnosti operativnog zahvata. Svi bolesnici su osjećali bolove prije 
operacije (medijan 8, interkvartilni raspon 7-9), dok je prisutnost boli značajno smanjena nakon operacije kod svih bolesnika 
(medijan 2, interkvartilni raspon 1,75-3). Rezultati su pokazali statistički značajno poboljšanje kliničke slike nakon primjene 
vertebroplastike u liječenju prijeloma kralješka uslijed plasmacitoma.
Ključne riječi: Vertebroplasika; Kralježnica, prijelomi; Plazmocitom; Hrvatska
